This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (22)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Dermatology  • Connective Tissue Diseases  • Rheumatology, Other  • Cardiovascular Disease/ Myocardial Infarction  • Immunologic Disorders  • Alert me on articles by topic

A Complex Challenge

Arch Intern Med. 2003;163:1507-1510.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

TWO IMPORTANT features of the epidemiology of systemic lupus erythematosus (SLE) have become apparent in recent years. First, probably because of increased awareness and testing, the incidence of SLE appears to have tripled to 5.56 per 100 000 population, with an estimated prevalence of 130 per 100 000.¹ Second, although the survival of patients with SLE has markedly improved, with 10-year survival rates of over 80%,^1-2 mortality is still substantial. More than a third of all SLE deaths occur among persons younger than 45 years, and annual mortality has increased 1.6-fold over the last 2 decades.³ Many more patients suffer considerable morbidity and loss of quality of life. The major role of accelerated or "premature" atherosclerotic cardiovascular and cerebrovascular disease (ASCVD) in the morbidity and mortality of patients with SLE is now well established. Recently, new research has provided important insights into the scope and mechanisms of atherosclerotic vascular disease in lupus. . . . [Full Text of this Article]

RELATED LETTER

Risks and Benefits of Statins in Lupus Erythematosus
Bernard Noël
Arch Intern Med. 2004;164(1):107-108.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Autoimmune-mediated atherothrombosis
Matsuura and Lopez
Lupus 2008;17:879-888.
ABSTRACT  

Systemic inflammation as a risk factor for atherothrombosis
van Leuven et al.
Rheumatology (Oxford) 2008;47:3-7.
ABSTRACT | FULL TEXT  

Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus
Martinez-Berriotxoa et al.
Lupus 2007;16:810-816.
ABSTRACT  

Cardiac involvement in systemic inflammatory diseases
Knockaert
Eur Heart J 2007;28:1797-1804.
ABSTRACT | FULL TEXT  

Exploring new territory: the move towards individualised treatment
Haubitz
Lupus 2007;16:227-231.
ABSTRACT  

Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics
Kavey et al.
Circulation 2006;114:2710-2738.
ABSTRACT | FULL TEXT  

Mycophenolate mofetil: an overview
Sinclair and Baildon
Lupus 2006;15:70-77.
 

Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Ruiz-Irastorza et al.
Lupus 2006;15:577-583.
ABSTRACT  

Atherogenesis in rheumatology
van Leuven et al.
Lupus 2006;15:117-121.
ABSTRACT  

Oxidized low-density lipoprotein and {beta}2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis
Lopez et al.
Lupus 2006;15:80-86.
ABSTRACT  

QT-interval parameters are increased in systemic lupus erythematosus patients
Cardoso et al.
Lupus 2005;14:846-852.
ABSTRACT  

Proinflammatory Cytokine Genes Are Constitutively Overexpressed in the Heart in Experimental Systemic Lupus Erythematosus: A Brief Communication
Tomita et al.
Exp. Biol. Med. 2004;229:971-976.
ABSTRACT | FULL TEXT  

Imaging Findings in Systemic Lupus Erythematosus
Lalani et al.
RadioGraphics 2004;24:1069-1086.
ABSTRACT | FULL TEXT  

Dobutamine stress echocardiography in women with systemic lupus erythematosus: increased occurrence of left ventricular outflow gradient
Codish et al.
Lupus 2004;13:101-104.
ABSTRACT  

Risks and Benefits of Statins in Lupus Erythematosus
Noel
Arch Intern Med 2004;164:107-108.
FULL TEXT